In San Francisco, Multiply Labs revealed a significant achievement in advancing the production of cell and gene therapies. The company, recognized for its prowess in robotic biomanufacturing, has embraced NVIDIA's Isaac and GR00T technologies to enhance its operations. By incorporating cutting-edge robotics simulation and perception tools, Multiply Labs has ushered in a new era for the industry, departing from traditional manual methods to a more automated approach. This shift comes at a crucial time as cell and gene therapies, known for their transformative impact, are gaining momentum in the medical field.